Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
about
Cardiovascular Cascade Genetic Testing: Exploring the Role of Direct Contact and TechnologyThe genetics and screening of familial hypercholesterolaemiaFamilial hypercholesterolemia: Review of diagnosis, screening, and treatmentChallenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaOptimizing Treatment of Familial Hypercholesterolemia in Children and AdolescentsThe panorama of familial hypercholesterolemia in Latin America: a systematic review.Cholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia.PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemiaHomozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and ManagementLong-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemiaThe lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.The distribution and characteristics of LDL receptor mutations in China: A systematic reviewNew data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse-led clinics.The Draupadi of dyslipidemia: Familial hypercholesterolemiaThe Treatment of Disorders of Lipid MetabolismKnowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.My Approach to the Patient With Familial Hypercholesterolemia.Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.Recommendations for the management of patients with familial hypercholesterolemia.Genetics of familial hypercholesterolemia.Improving the odds: ezetimibe and cardiovascular disease.Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention.Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacology.Challenges in the care of familial hypercholesterolemia: a community care perspective.Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab.Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.Familial Hypercholesterolaemia in the Era of Genetic Testing.The efficacy of evolocumab in the management of hyperlipidemia: a systematic review.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Psychological issues and cognitive impairment in adults with familial hypercholesterolemia.Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap?Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
P2860
Q26752300-1CC3FDD2-74E3-441F-9AEE-DF78202C3429Q26753081-1F08CBE1-80B8-40B3-B70C-7E60C6BC142BQ26770143-85AA4F7A-3CDD-4D35-9B54-09417276D112Q26787050-7F55C07B-B9B5-4FEF-BB32-64F1A16CAD67Q26798119-A9B96336-4F76-4907-8075-051E69113DF0Q30244116-556E4BB5-2066-4AC7-9398-FA9793B5842AQ33552173-4C23CCB5-F90F-4280-8E06-CB063BBB1701Q33625574-C6BBF61D-9A0C-4FDD-A395-7AAC52588E52Q33728343-B3DDB800-691D-497C-BAC3-C0E7BCC2A64EQ34071937-38377DF0-9E19-46EB-A868-A25D4C157DE5Q34072528-433DE0BD-AF7A-4659-833B-5087663ABE75Q35756629-96FBCCF5-7218-4440-9294-03A37614BEACQ36040683-34D80D59-77F9-4089-A541-1DD50AF6594AQ36069577-175039B4-DCBB-4DF1-B1A9-27C9DFCD82EAQ36076131-FA0270C7-D200-4ABB-B01E-2A3A602D4A83Q36320640-FCCCEBF8-9524-48A7-A653-47D90E1ED10FQ36366067-416C4134-D491-4EB4-AF9E-8225F5D63B78Q36824103-D2464C6F-BA57-4B2C-8D85-D92A5D713F15Q36867393-373F171F-99A3-4EAF-BE0B-3B93C0465BD0Q36882866-C355F83B-6EA0-452C-9815-FFB68CC96890Q37102772-C34201E1-4D99-49FD-A712-5792AAA301ECQ37549374-5B286F42-7065-41B3-817E-9367BE9922F0Q37731770-B663F8B7-DB7B-47C3-B2C2-5113459C3319Q38217797-1E229C2E-F2C2-43D0-BB6A-43F74582BE48Q38268915-8BF7C0D8-3273-4B50-A9DF-22DFA7623475Q38364881-D419A7F6-4740-4624-8B02-4ED8F43EC26EQ38393758-C9F29D9C-EBD3-4875-9AD7-C624FA8482D0Q38415231-0177795B-C4E7-409C-A4E1-FFA2FFD5D5ABQ38424373-3FC7512C-C1E8-43C5-B3D1-3D6AA4D91E19Q38570558-52D53FD2-2CC1-4E2F-8589-6153103B6733Q38575066-9D14D0DF-3B8A-48DA-B4F9-DCE24C251D02Q38596398-B6155037-7396-46E9-B2D4-3E1D1052A5FAQ38724969-BDEB4046-5825-4916-BD40-64DABF265FBDQ38728768-59F85DE1-C701-44EF-BAC3-AE189251DEA7Q38784635-AC764D23-9E98-45BF-84B3-BED7A5C7CE3CQ38794761-434BFAA4-ED41-46C9-8686-71246AFEEB4EQ38839105-964D2EA3-807D-4268-91ED-97449015285BQ39354282-73DE17D8-4638-462F-8D8B-F8AA88FA0E74Q41444737-03A5C92B-71F6-4D09-A6F4-323E249AAA3DQ41613122-437D5CAD-9112-458C-9115-56E35B1C6389
P2860
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Integrated guidance on the car ...... e International FH Foundation.
@en
type
label
Integrated guidance on the car ...... e International FH Foundation.
@en
prefLabel
Integrated guidance on the car ...... e International FH Foundation.
@en
P2093
P1476
Integrated guidance on the car ...... e International FH Foundation.
@en
P2093
Albert Wiegman
Andrey V Susekov
Brian Tomlinson
David R Sullivan
Eric Bruckert
Frederick J Raal
Gerald F Watts
Joep Defesche
John J P Kastelein
Khoo Kah Lin
P304
P356
10.1016/J.IJCARD.2013.11.025
P407
P577
2013-11-20T00:00:00Z